StockWatch
·

Syngene International Ltd

BSE: 539268

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-125.03283.83692.681.1KQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
-16.991.7320.4539.17Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue960.00+15.1%834.40+0.5%830.10+3.9%799.30-15.7%948.40+8.1%877.10+6.8%821.30
Other Income21.60+49.0%14.50+2.1%14.20-14.5%16.60-9.8%18.40+2.2%18.00+9.8%16.40
Total Income981.60+15.6%848.90+0.5%844.30+3.5%815.90-15.6%966.80+8.0%895.10+6.9%837.70
EXPENSES
Expenditure777.50+3.3%753.00-0.9%760.10+3.9%731.70-0.9%738.10+1.8%725.30+1.7%713.40
Tax48.50+256.6%13.60-24.4%18.00+76.5%10.20-81.2%54.30+16.3%46.70+68.6%27.70
PROFIT
PBT196.70+553.5%30.10-64.3%84.20+0.0%84.20-63.2%228.70+34.7%169.80+36.6%124.30
Net Profit148.20+798.2%16.50-75.1%66.20-10.5%74.00-57.6%174.40+41.7%123.10+27.4%96.60
KEY METRICS
OPM %28.84%+39.35pp-10.51%-31.89pp21.38%+0.35pp21.03%-11.66pp32.69%+26.67pp6.02%+5.14pp0.88%
NPM %15.10%+13.16pp1.94%-5.90pp7.84%-1.23pp9.07%-8.97pp18.04%+4.29pp13.75%+2.22pp11.53%
EPS3.68+797.6%0.41-75.2%1.65-10.3%1.84-57.6%4.34+41.4%3.07+27.4%2.41

Corporate Events

Board MeetingSYNGENE
2026
29Jul

Board Meeting

The 33rd AGM of the Company will be held on Wednesday, July …

BSE Filing
DividendSYNGENE
2026
26Jun

₹1.25 / share

BSE Filing
Board MeetingSYNGENE
2026
29Apr

Board Meeting

The Board of Directors of the Company, at its Meeting held o…

BSE Filing
Board MeetingSYNGENE
2024
23Oct

Board Meeting

Consider and approve the un-audited standalone and consolida…

BSE Filing
DividendSYNGENE
2024
28Jun

₹1.25 / share

BSE Filing
Board MeetingSYNGENE
2024
24Apr

Board Meeting

Consider and approve the audited standalone and consolidated…

BSE Filing
Board MeetingSYNGENE
2024
25Jan

Board Meeting

Consider and approve the unaudited standalone and consolidat…

BSE Filing
Board MeetingSYNGENE
2023
17Oct

Board Meeting

Consider and approve the unaudited standalone and consolidat…

BSE Filing